Enterprise aggregate value in biopharma subsectors worldwide 2023
As of May 2023, the (pure play) biotechnology subsector's aggregated enterprise value was estimated at some 227 billion U.S. dollars. The largest subsector was by far pharma, which also includes many companies that are active in biotech. This statistic shows the aggregate enterprise value of select subsectors of the biopharma economy worldwide as of 2023.